ArticleAnnals of hematology2026
A novel frameshift deletion in SLC25A38 and its role in mitochondrial dysfunction: A case study of sideroblastic anemia in a child from Iran.
Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sideroblastic anemia (SA) is a rare hematological condition characterized by the accumulation of iron in the mitochondria of erythroid precursor cells, resulting in the formation of sideroblastic rings. It occurs in both inherited and acquired forms. A prevalent subtype of congenital sideroblastic anemia (CSA) results from autosomal recessive mutations in the SLC25A38 gene. This investigation included a clinical and genetic evaluation of a family with a child diagnosed with pyridoxine-refractory SA. Whole Exome Sequencing (WES) was performed on the patient to detect the genetic variation. Afterwards, to examine segregation, Sanger sequencing of the related gene was conducted on the patient’s parents and the fetus of this family. On the other hand, the proband’s aunt and her husband, whose daughter died from symptoms similar to SA, were also evaluated for this variation. The next step involved molecular docking studies for the SLC25A38 protein pre- and post-variation. The WES analysis demonstrated the c.482_485del (p. Ile161ThrfsTer4) variant in the SLC25A38 gene, present in the probands as homozygotes and in the parents as heterozygotes. The chemical binds and stability of the protein in the mutant form was observed to be diminished in comparison to the wild form. This study enabled the reclassification of the SLC25A38: c.482_485del from likely pathogenic to pathogenic, which will significantly assist specialists in making decisions about this variant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.